What an exciting week in the world of the diabetes with the ADA Virtual Scientific Sessions, FDA approval of a new faster acting insulin lispro and the next generation Freestyle Libre 2 continuous glucose monitoring system. Lilly has received FDA approval for their new faster acting insulin lispro (Lyumjev) available in U-100 and U-200 formulations. This new insulin will be available through Lilly Insulin Value Program ($35/month copay). More details are provided in link below.
Secondly, the next generation of the Free Style Libre has been approved. Freestyle Libre 2 integrated continuous glucose monitoring system now has optional, real time alarms (which Freestyle Libre 14 day lacked). Similar to Freestyle Libre 14 day, this new generation integrated is placed on the upper arm for 14 days. Abbott (maker of Freestyle Libre) is still working to bring apps for Libre to U.S. Please click on link below for additional details.
Please share your thoughts and subscribe to receive my blogs.
#FDA #Lyumjev #Libre2 #next generation
Follow me on Twitter and Facebook @ReecesPiecesDi and Instagram.